COMPOUNDING SERIES - Fighting Insanitary Conditions Before They Start

As more small organizations begin sterile compounding, understanding Immediate Use and Category 1 Compounding is critical. This session breaks down the definitions, key differences, and regulatory requirements for these compounding types when conducted in Segregated Compounding Areas (SCAs). We'll discuss when these practices are appropriate, how to stay compliant, and practical considerations for implementation.

1. Distinguish between Immediate-Use and Category 1 Compounding, including definitions, requirements, and appropriate use cases.
2. Explain regulatory expectations for conducting these compounding activities in SCAs.
3. Evaluate practical considerations and compliance strategies for implementing Immediate-Use and Category 1 practices in small organization

REGISTER

The Compounding Knowledge educational series is supported through an educational grant from Wolters Kluwer.